نتائج البحث - McMeekin, D Scott
- يعرض 1 - 20 نتائج من 23
- اذهب إلى الاصفحة التالية
-
1
-
2
Phase II Trial of Ixabepilone As Second-Line Treatment in Advanced Endometrial Cancer: Gynecologic Oncology Group Trial 129-P حسب Dizon, Don S., Blessing, John A., McMeekin, D. Scott, Sharma, Sudarshan K., DiSilvestro, Paul, Alvarez, Ronald D.
منشور في 2009نص -
3
A PHASE II TRIAL OF THALIDOMIDE IN PATIENTS WITH REFRACTORY ENDOMETRIAL CANCER AND CORRELATION WITH ANGIOGENESIS BIOMARKERS: A GYNECOLOGIC ONCOLOGY GROUP STUDY حسب McMeekin, D. Scott, Sill, Michael W., Benbrook, Doris, Darcy, Kathleen M., Stearns-Kurosawa, Deborah J., Eaton, Lynne, Yamada, S. Diane
منشور في 2007نص -
4
A phase II evaluation of nanoparticle, albumin-bound (nab) paclitaxel) in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube, or primary peritoneal... حسب Coleman, Robert L., Brady, William E., McMeekin, D. Scott, Rose, Peter G., Soper, John T., Lentz, Samuel S., Hoffman, James S., Shahin, Mark S.
منشور في 2011نص -
5
-
6
Phase III Trial of Four Cisplatin-Containing Doublet Combinations in Stage IVB, Recurrent, or Persistent Cervical Carcinoma: A Gynecologic Oncology Group Study حسب Monk, Bradley J., Sill, Michael W., McMeekin, D. Scott, Cohn, David E., Ramondetta, Lois M., Boardman, Cecelia H., Benda, Jo, Cella, David
منشور في 2009نص -
7
A Phase I Study of Concurrent Weekly Topotecan and Cisplatin Chemotherapy with Whole Pelvic Radiation Therapy in Locally Advanced Cervical Cancer: a Gynecologic Oncology Group Stud... حسب Rose, Peter G., Sill, Michael W., McMeekin, D. Scott, Ahmed, Amina, Salani, Ritu, Yamada, S. Diane, Wolfson, Aaron, Fusco, Nancy, Fracasso, Paula M.
منشور في 2011نص -
8
A phase II evaluation of Irofulven (IND#55804, NSC#683863) as second-line treatment of recurrent or persistent intermediately platinum-sensitive ovarian or primary peritoneal cance... حسب Schilder, Russell J., Blessing, John A., Shahin, Mark S., Miller, David S, Tewari, Krishnansu Sujata, Muller, Carolyn Y., Warshal, David, McMeekin, D. Scott, Rotmensch, Jacob
منشور في 2010نص -
9
Phase II trial of Cetuximab in the Treatment of Persistent or Recurrent Squamous or Non-Squamous Cell Carcinoma of the Cervix: A Gynecologic Oncology Group Study حسب Santin, Alessandro D., Sill, Michael W., McMeekin, D. Scott, Leitao, Mario M., Brown, Jubilee, Sutton, Gregory P., Van Le, Linda, Griffin, Patricia, Boardman, Cecelia H.
منشور في 2011نص -
10
Phase II Trial of Bevacizumab in Recurrent or Persistent Endometrial Cancer: A Gynecologic Oncology Group Study حسب Aghajanian, Carol, Sill, Michael W., Darcy, Kathleen M., Greer, Benjamin, McMeekin, D. Scott, Rose, Peter G., Rotmensch, Jacob, Barnes, Mack N., Hanjani, Parviz, Leslie, Kimberly K.
منشور في 2011نص -
11
Ultra-early Predictive Assay for Treatment Failure Using Functional Magnetic Resonance Imaging and Clinical Prognostic Parameters in Cervical Cancer حسب Mayr, Nina A., Yuh, William T. C., Jajoura, David, Wang, Jian Z., Lo, Simon S., Montebello, Joseph F., Porter, Kyle, Zhang, Dongqing, McMeekin, D. Scott, Buatti, John M.
منشور في 2010نص -
12
A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass حسب Moore, Richard G., McMeekin, D. Scott, Brown, Amy K., DiSilvestro, Paul, Miller, M. Craig, Allard, W. Jeffrey, Gajewski, Walter, Kurman, Robert, Bast, Robert C., Skates, Steven J.
منشور في 2008نص -
13
Etiologic Heterogeneity in Endometrial Cancer: Evidence from a Gynecologic Oncology Group Trial حسب Brinton, Louise A., Felix, Ashley S., McMeekin, D. Scott, Creasman, William T., Sherman, Mark E., Mutch, David, Cohn, David E., Walker, Joan L., Moore, Richard G., Downs, Levi S., Soslow, Robert A., Zaino, Richard
منشور في 2013نص -
14
Relationships of Tubal Ligation to Endometrial Carcinoma Stage and Mortality in the NRG Oncology/Gynecologic Oncology Group 210 Trial حسب Felix, Ashley S., Brinton, Louise A., McMeekin, D. Scott, Creasman, William T., Mutch, David, Cohn, David E., Walker, Joan L., Moore, Richard G., Downs, Levi S., Soslow, Robert A., Zaino, Richard, Sherman, Mark E.
منشور في 2015نص -
15
A Phase 1b Dose Escalation Study of Ipafricept (OMP-54F28) in Combination with Paclitaxel and Carboplatin in Patients with Recurrent Platinum-Sensitive Ovarian Cancer حسب Moore, Kathleen N., Gunderson, Camille, Sabbatini, Paul, McMeekin, D. Scott, Mantia-Smaldone, Gina, Burger, Robert, Morgan, Mark A., Kapoun, Ann M., Brachmann, Rainer Karl, Stagg, Robert, Farooki, Azeez, O’Cearbhaill, Roisin E
منشور في 2019نص -
16
Phase II Trial of Trastuzumab in Women with Advanced or Recurrent, HER2-Positive Endometrial Carcinoma: a Gynecologic Oncology Group Study حسب Fleming, Gini F., Sill, Michael W., Darcy, Kathleen M., McMeekin, D. Scott, Thigpen, J. Tate, Adler, Lisa M., Berek, Jonathan S., Chapman, Julia A., DiSilvestro, Paul A., Horowitz, Ira R., Fiorica, James V.
منشور في 2009نص -
17
Associations between etiologic factors and mortality after endometrial cancer diagnosis: The NRG Oncology/Gynecologic Oncology Group 210 Trial حسب Felix, Ashley S, McMeekin, D Scott, Mutch, David, Walker, Joan L, Creasman, William T, Cohn, David E, Ali, Shamshad, Moore, Richard G, Downs, Levi S, Ioffe, Olga B, Park, Kay J, Sherman, Mark E, Brinton, Louise A
منشور في 2015نص -
18
A Phase II Trial of Brivanib in Recurrent or Persistent Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group Study حسب Powell, Matthew A., Sill, Michael W., Goodfellow, Paul J., Benbrook, Doris M., Lankes, Heather A., Leslie, Kimberly K., Jeske, Yvette, Mannel, Robert S., Spillman, Monique A, Lee, Paula S., Hoffman, James S., McMeekin, D. Scott, Pollock, Pamela M.
منشور في 2014نص -
19
A Phase II Evaluation of Aflibercept in the Treatment of Recurrent or Persistent Endometrial Cancer: a Gynecologic Oncology Group study حسب Coleman, Robert L., Sill, Michael W., Lankes, Heather A., Fader, Amanda Nickles, Finkler, Neil J., Hoffman, James S., Rose, Peter G., Sutton, Gregory P., Drescher, Charles W., McMeekin, D. Scott, Hu, Wei, Deavers, Michael, Godwin, Andrew K., Alpaugh, R. Katherine, Sood, Anil K.
منشور في 2012نص -
20
Phase III Trial: Adjuvant Pelvic Radiation Therapy Versus Vaginal Brachytherapy Plus Paclitaxel/Carboplatin in High-Intermediate and High-Risk Early-Stage Endometrial Cancer حسب Randall, Marcus E., Filiaci, Virginia, McMeekin, D. Scott, von Gruenigen, Vivian, Huang, Helen, Yashar, Catheryn M., Mannel, Robert S., Kim, Jae-Weon, Salani, Ritu, DiSilvestro, Paul A., Burke, James J., Rutherford, Thomas, Spirtos, Nick M., Terada, Keith, Anderson, Penny R., Brewster, Wendy R., Small, William, Aghajanian, Carol A., Miller, David S.
منشور في 2019نص